MS Patients Show Robust T-Cell Response to mRNA COVID-19 Vaccines
MS patients receiving anti-CD20 monoclonal antibody treatment can still mount T-cell responses
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.